Rucaparib Inhibits Lung Adenocarcinoma Cell Proliferation and Migration via the SHCBP1/CDK1 Pathway

Researchers discovered that src homolog and collagen homolog binding protein 1 (SHCBP1) was overexpressed in lung adenocarcinoma (LUAD) tissues and was associated with a poor prognosis.